Xtant Medical (XTNT) Loses 3.85% on May 13

Equities Staff  |

Shares of Xtant Medical Holdings Inc (NYSE: XTNT) moved 3.85% Friday.

As of 12:05:12 est, Xtant Medical is currently sitting at $0.51 and has fallen $0.0206 per share in trading so far.

Xtant Medical has moved 19.02% over the last 30 days and has a YTD change of 4.48% based on the most recent close.

The company is set to release earnings on 2022-08-04.

For technical charts, analysis, and more on Xtant Medical visit the company profile.

About Xtant Medical Holdings Inc

Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant's people are dedicated and talented, operating with the highest integrity to serve our customers.

To get more information on Xtant Medical Holdings Inc and to follow the company's latest updates, you can visit the company's profile page here: Xtant Medical Holdings Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement



Market Movers

Sponsored Financial Content